HAP1 and Huntington disease: In addition to Huntington’s disease, previous studies indicated that STB/HAP1 could also have protective effects against neurodegeneration in spinal and bulbar muscular atrophy [13], spinocerebellar ataxia type 17 [14], Machado-Joseph disease [15], and Joubert syndrome [16].